Metabomed raised €16M in a Series A round in Apr 2016. The company is based in Yavne, Israel. Investors in the round: Arkin Holdings, Boehringer Ingelheim Venture Fund, MS Ventures and 2 others. Data as of 7 Aug 2026.
No source on record — unverified.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
